These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11377609)

  • 21. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease.
    Ballard C; Corbett A; Sharp S
    Expert Rev Neurother; 2011 Mar; 11(3):327-9. PubMed ID: 21375436
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathological and neuropsychological changes in Alzheimer's disease. Relationship of biologic markers to behavioral markers.
    Pirozzolo FJ; Inbody SB; Sims PA; Strittmatter WJ; Baskin D
    Clin Geriatr Med; 1989 Aug; 5(3):425-40. PubMed ID: 2680026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-dementia therapy. Critique of guidelines].
    MMW Fortschr Med; 2001 Oct; 143(41):58. PubMed ID: 11721667
    [No Abstract]   [Full Text] [Related]  

  • 26. [The characteristics of Alzheimer's Disease Units in relation to neuropsychological tests].
    Sorrentino GC; Caffari B; Vanacore N; Maggini M; Raschetti R
    Ann Ist Super Sanita; 2005; 41(1):63-8. PubMed ID: 16037652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Alzheimer's endpoints?
    Aldridge S
    Nat Biotechnol; 2008 May; 26(5):482. PubMed ID: 18464762
    [No Abstract]   [Full Text] [Related]  

  • 28. [Update on current care guidelines. The diagnosis and medical treatment of memory disorders].
    Suhonen J; Pirttilä T; Erkinjuntti T; Koponen H; Makkonen M; Puurunen M; Raivio M; Rinne J; Rosenvall A; Strandberg T; Vanninen R; Vataja R; ; ; ; ;
    Duodecim; 2010; 126(18):2167-8. PubMed ID: 21072963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimated prevalence of Alzheimer's disease in the United States.
    Evans DA
    Milbank Q; 1990; 68(2):267-89. PubMed ID: 2233632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Feldman H; Anand R; Blesa R; Dubois B; Gray J; Homma A; Mohr E; Morris JC; Parys W; Raschig A; Robillard A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuropsychological exploration in dementia: presentation of a neuropsychologic battery in the study of Alzheimer's disease].
    Gil i Saladié D; Jarne i Esparcia A; Delgado i González M; Peña i Casanova J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990; 18(1):47-53. PubMed ID: 2330849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
    Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
    Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical treatment strategies for patients with Alzheimer's disease.
    Christensen DD; Lin P
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S17-23. PubMed ID: 18664338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncertain progress on the fuzzy boundaries of Alzheimer's disease: reading between the guidelines.
    Whitehouse PJ; George DR
    J Alzheimers Dis; 2011; 26(1):1-5. PubMed ID: 21743133
    [No Abstract]   [Full Text] [Related]  

  • 35. Guidelines for managing Alzheimer's disease: part I. Assessment.
    Cummings JL; Frank JC; Cherry D; Kohatsu ND; Kemp B; Hewett L; Mittman B
    Am Fam Physician; 2002 Jun; 65(11):2263-72. PubMed ID: 12074525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New guidelines for Alzheimer's and related dementias.
    Bailey C
    Colo Nurse; 1997 Mar; 97(1):11. PubMed ID: 9095789
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease. Proceedings of a meeting. New York, New York, July 26, 1994.
    Int Psychogeriatr; 1996; 8(2):155-344. PubMed ID: 9091069
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical practice. Early Alzheimer's disease.
    Mayeux R
    N Engl J Med; 2010 Jun; 362(23):2194-201. PubMed ID: 20558370
    [No Abstract]   [Full Text] [Related]  

  • 39. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Ferris SH; Lucca U; Mohs R; Dubois B; Wesnes K; Erzigkeit H; Geldmacher D; Bodick N
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():34-8. PubMed ID: 9305514
    [No Abstract]   [Full Text] [Related]  

  • 40. Mild cognitive impairment, healthy aging and Alzheimer's disease.
    Wu CK
    Med Health R I; 2008 May; 91(5):132-3. PubMed ID: 18549037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.